COSA 2015* Ngan Huynh
Bristol-Myers Squibb, VIC, Australia
Presentations this author is a contributor to:
Safety and efficacy of nivolumab in an ongoing trial of a PD-L1+/- patient population with metastatic non-small cell lung cancer (#201)
3:00 PM
Maen Hussein
Posters1